Previously, it has been suggested that patients with FD and LVH also had higher plasma levels of TNFR2, while patients with late gadolinium enhancement demonstrated increased TNFR1 and TNFR2 levels [54]. This evidence concerns the gene TNFRSF1A and Fabry disease.